Dichloro(ethylenediamine)platinum(II)
CAS: 14096-51-6
Ref. 3D-PAA09651
1g | 801,00 € | ||
2g | 1.160,00 € | ||
100mg | 194,00 € | ||
250mg | 364,00 € | ||
500mg | 517,00 € |
Información del producto
- (SP-4-2)-Dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)platinum
- Cpa 3
- Dichloro(1,2-diaminoethane)platinum
- Dichloro(1,2-ethanediamine)platinum
- Dichloro(ethane-1,2-diamine)platinum(II)
- Dichloroplatinum(2+) Ethane-1,2-Diyldiazanide
- Enplatin
- NSC 125181
- Platinum ethylenediamine dichloride
- Platinum(2+) Dichloride - Ethane-1,2-Diamine (1:1)
- Ver más sinónimos
- Platinum, dichloro(1,2-ethanediamine-N,N′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN,κN′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)-, (SP-4-2)-
- Platinum, dichloro(ethylenediamine)-
- cis-Dichloro ethylenediammine platinum
- cis-Dichloro(ethylenediamine)platinum
- cis-Dichloro(ethylenediamine)platinum(Ⅱ)
Dichloro(ethylenediamine)platinum (II) is a platinum-based anticancer drug that is used in the treatment of ovarian cancer. It binds to the phosphate group of DNA and forms a chelate ring with the DNA. This inhibits the cellular function of the DNA, preventing replication and transcription. The dichloro(ethylenediamine)platinum (II) molecule has two possible stereoisomers: cis-dichloro(ethylenediamine)platinum (II) or trans-dichloro(ethylenediamine)platinum (II). The cis form is more active than the trans form, but both are equally effective in inhibiting DNA synthesis. Dichloro(ethylenediamine)platinum (II) also reacts with chloride ions to form an ion pair complex that is taken up by cells. This complex disrupts cell metabolism and leads to apoptosis.
Propiedades químicas
Consulta técnica sobre: 3D-PAA09651 Dichloro(ethylenediamine)platinum(II)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.